Research Output per year
Personal profile
Research interests
Dr. Norah Palmateer joined Glasgow Caledonian University as a Senior Research Fellow in January 2016. She also holds an honorary NHS contract with Health Protection Scotland. Her main area of work relates to the epidemiology of infections among people who inject drugs - primarily hepatitis C - and the evaluation of interventions to prevent their transmission. She received a BScH in Life Sciences from Queen’s University (Canada), followed by an MSc in Epidemiology from the University of Edinburgh and a PhD in Public Health from the University of Glasgow. She is an author of over 30 academic papers in the areas of injecting drug use and blood-borne virus epidemiology.
Fingerprint Dive into the research topics where Norah Palmateer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 25 Similar Profiles
Hepacivirus
Medicine & Life Sciences
Pharmaceutical Preparations
Medicine & Life Sciences
Scotland
Medicine & Life Sciences
Hepatitis C
Medicine & Life Sciences
Syringes
Medicine & Life Sciences
Opiate Substitution Treatment
Medicine & Life Sciences
Harm Reduction
Medicine & Life Sciences
Drug Users
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2007 2019
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)
Hickman, M., Dillon, J. F., Elliott, L., De Angelis, D., Vickerman, P., Foster, G., Donnan, P., Eriksen, A., Flowers, P., Goldberg, D., Hollingworth, W., Ijaz, S., Liddell, D., Mandal, S., Martin, N., Beer, L. J. Z., Drysdale, K., Fraser, H., Glass, R., Graham, L. & 29 others, , 24 Sep 2019, In : BMJ Open. 9, 9, 12 p.Research output: Contribution to journal › Article
Open Access
File
Hepatitis C
Hepacivirus
Antiviral Agents
Pharmaceutical Preparations
Population
Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis
McAuley, A., Palmateer, N. E., Goldberg, D. J., Trayner, K. M. A., Shepherd, S. J., Gunson, R. N., Metcalfe, R., Milosevic, C., Taylor, A., Munro, A. & Hutchinson, S. J., May 2019, In : The Lancet HIV. 6, 5, p. e315-e324Research output: Contribution to journal › Article
Open Access
File
Harm Reduction
Cross-Sectional Studies
HIV
HIV Infections
Disease Outbreaks
Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs
Palmateer, N. E., Goldberg, D. J., Munro, A., Taylor, A., Yeung, A., Wallace, L. A., Mitchell, A., Shepherd, S. J., Gunson, R. N., Aitken, C. & Hutchinson, S. J., Jan 2018, In : Addiction. 113, 1, p. 80-90 11 p.Research output: Contribution to journal › Article
Open Access
File
Hepatitis B Vaccines
Prisons
Hepatitis B
Hepatitis B virus
Vaccination
Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era
Valerio, H., McAuley, A., Innes, H., Palmateer, N., Goldberg, D. J., Munro, A., Taylor, A. & Hutchinson, S. J., Feb 2018, In : International Journal of Drug Policy. 52, p. 115-122 8 p.Research output: Contribution to journal › Article
Open Access
File
Hepatitis C
Antiviral Agents
Pharmaceutical Preparations
Scotland
Population
HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype
Shepherd, S. J., McDonald, S. A., Palmateer, N. E., Gunson, R. N., Aitken, C., Dore, G. J., Goldberg, D. J., Applegate, T. L., Lloyd, A. R., Hajarizadeh, B., Grebely, J. & Hutchinson, S. J., Jan 2018, In : Journal of Medical Virology. 90, 1, p. 120-130 10 p.Research output: Contribution to journal › Article
Open Access
File
Virus Diseases
Hepacivirus
Genotype
Infection
Odds Ratio